Will Wells Fargo receive any new consent order from Fed, OCC, CFPB, or DOJ by year-end 2026?
Current Prediction
Prediction History
14th consent order closed in March 2026 extending the 2025 unidirectional pattern. No new enforcement disclosed. REGULATORY_EXPOSURE = MANAGEABLE confirmed and strengthened. Residual tail risk remains from new markets book expansion and legacy-issue surfacing, but Q1 provided no pipeline signal.
Why This Question Matters
The tail-risk test for regulatory exposure. 13 orders closed since 2019, 7 in 2025. Any new order would reactivate the 2016 scandal public memory and shift the regulatory assessment to ELEVATED.
Prediction Distribution
Individual Predictions(1 runs)
Q1 strengthened the low-probability case. 14th consent order closed in March 2026 with no new orders disclosed, extending the 2025 unidirectional pattern. Asset cap removal validation still holds; management posture remains execution-focused with permanent risk infrastructure. Residual tail risk comes from legacy-issue surfacing and new-product areas like the expanding markets book, but no known pipeline issue exists. Slightly below the prior 0.15 on the incremental closure and absence of any surprise.
Resolution Criteria
Resolves YES if Wells Fargo discloses (via 8-K or quarterly SEC filing) any new consent order, formal agreement, or cease-and-desist order from the Federal Reserve, OCC, CFPB, or DOJ between April 13 2026 and December 31 2026. Resolves NO if no such order is disclosed during that window.
Resolution Source
Wells Fargo 8-K filings, 10-Q filings, regulator announcements
Source Trigger
New regulatory orders from any body are the tail-risk trigger for regulatory exposure
Full multi-lens equity analysis